Assays for the concentration of p-tau231 and tau phosphorylated as serine-199 (p-tau199) tightly correlate with p-tau181, with all three epitopes found to be equally and significantly raised in AD patients compared to patients with other dementias, and controls [112]. The gene discussed is MAPT; the disease is dementia.